Page 23 - Read Online
P. 23

Bekisz et al. Plast Aesthet Res 2022;9:61  https://dx.doi.org/10.20517/2347-9264.2022.69  Page 5 of 8

               challenges that may necessitate deviations or conversions to secondary options, such as tendon grafting or
               use of alternative donor nerves. Intraoperatively, success is contingent not simply upon meticulous
               microsurgical dissection and anastomosis of the vessels and nerves but upon correct positioning of the
               muscle and tensioning of tendons to enable their excursion and provide the desired movement. In the early
               postoperative period, careful monitoring of the transferred muscle is critical to ensure its survival and
               successful healing of the recipient and donor sites. If all the above are accomplished, the final and most
               important component will involve the rehabilitation and retraining process, which will demand intimate
               and coordinated collaboration with hand and occupational therapy colleagues to achieve a meaningful
               functional outcome.


               VASCULARIZED COMPOSITE ALLOTRANSPLANTATION
               In keeping with the oft-cited surgical principle of replacing “tissue losses in kind” , VCA of the hand and
                                                                                     [47]
               upper extremity seeks to restore form and function following limb loss in a manner that is not possible with
               other reconstructive modalities. Although fewer than 25 years have passed since the first successful hand
               transplant, the procedure has now been performed in at least a dozen countries and on more than 100
               patients. High mortality and devastating graft loss rates have been reported for combination VCA
               procedures that involve upper extremity transplantation in conjunction with a craniofacial or lower
               extremity transplant; however, isolated unilateral or bilateral upper extremity VCA has proven to be a more
               reliably attainable goal. The patient survival rate has been reported to be 99%, while overall long-term graft
               survival is approximately 85% across all recipients and more than 95% with stringent adherence to an
               immunosuppressive medication regimen [48,49] .


               However, it is that same regimen of immunosuppressive agents that underpins the shortcomings and
               drawbacks of VCA. Since its inception, the field of transplantation has been plagued by the need for lifelong
               use of these medications. Their well-described toxicities leading to both graft and organ damage as well as
               increased susceptibility to infection and malignancy are certainties that all transplant recipients accept.
               While much progress has been made towards inducing chimerism and tolerance [50,51] , at present, these
               remain theoretical goals, the promise of which has yet to be fully realized. Until the ability to minimize or
               eliminate immune responses to transplanted tissue in the absence of pharmacologic intervention becomes a
               reality, constant diligence will remain necessary to balance the harmful effects of immunosuppressants
               against the risk of graft rejection.


               With respect to VCA specifically, discussions of its ethics and risk-benefit profile often cite that, unlike
               transplantation of a solid organ, such as a liver or kidney, VCA involving the face or an upper extremity is
               life-changing but not life-saving. Nonetheless, the psychosocial benefits of VCA demonstrate the substantial
               impact that transplantation can have on an individual’s life, in many circumstances easing the burdens of
               isolation, loneliness, and loss of personhood that may accompany the “social death” experienced following a
               disfiguring injury [52,53] . In 2016, Breidenbach et al. performed a statistical analysis of hand transplantation
               with the aim of discerning whether the procedure met the necessary threshold to be deemed the standard of
                   [54]
               care . The group concluded that when considered against solid organ transplants, hand transplantation
               demonstrates a superior ability to attain adequate immunosuppression and has a lower risk of chronic graft
               rejection and a decreased incidence of renal failure. This finding, in combination with a functional ability
               that was superior to that of the prosthetic devices available at the time, suggested that hand and upper
               extremity VCA had merits.


               Despite the wealth of literature published on the subject and the growing number of centers globally that are
               offering the procedure, assessment of functional outcomes following hand transplantation has proven
   18   19   20   21   22   23   24   25   26   27   28